Lightsheer Laser for Hair Removal also available on the following treatment dates. Call for more details.
Upcoming Treatment Dates: May 10, June 9, 2016 Schedule your appointment today.
Facial Veins, Rosacea, and Pigmented Lesions Are Treated Using the Safe and Effective VersaPulse® Laser
The VersaPulse® laser utilizes a green-light wavelength that safely targets superficial blood vessels and pigmented lesions. This laser uses a variable pulse width that allows selective treatments of a wide variety of vascular conditions with minimal bruising or down-time.
This variable pulsed technology allows the physician or laser specialist to safely treat the patient's vascular lesions without harming the surrounding skin cells. Vascular and pigmented conditions the VersaPulse® laser can effectively treat include:
- Facial Telangiectasia (broken capillaries)
- Rosacea management (a skin disease where redness and flushing of the face occurs); Cherry Hemangiomas (red moles)
- Port Wine Stains (red birthmark)
- Vascular birthmarks
- Solar Lentigines (benign brown spots, freckles)
- Unwanted Tattoos
Vascular lesions or pigmented lesions: $375 per 20 minute treatment or $250 per 10 minute treatment
FAQ's about the VersaPulse® Laser
The word LASER is an acronym for Light Amplification by the Stimulated Emission of Radiation. Today's advanced laser technology allows us to safely and effectively treat many benign skin lesions, on an out-patient basis.
How does a VersaPulse® laser work?
The VersaPulse® laser uses an intense beam of light to gently remove unwanted, damaged, or diseased cells/lesions without harming the surrounding healthy cells. The VersaPulse® laser's green-light energy is delivered in short, adjustable pulses, which minimizes bruising and discomfort.
How many treatments are required?
This depends on several factors such as: size, location, depth, and the color of your vascular or pigmented lesion. Spider Veins on the face and Cherry Hemangiomas generally diminish with one or two treatments, while darker or deeper birthmarks may require multiple treatments. Port Wine Stains and Hemangiomas are safely treated and respond well with a series of laser treatments.
Rosacea is a disease that requires continual management. However, the VersaPulse® laser dramatically reduces the redness and flushing nature that Rosacea causes. Pigmented lesions require 1 to 3 sessions for safe removal. Treatments should be placed 4 to 6 weeks apart to allow your body the adequate time to remove the maximum amount of targeted cells. You will continue to see a lightening of your lesions after each treatment as your body disposes of the coagulated cells that have been treated with the VersaPulse® laser.
Are VersaPulse® laser treatments safe?
VersaPulse® lasers have been used in thousands of treatments. When properly performed by a trained physician or laser specialist, the VersaPulse® treatments are extremely safe and effective. There are many benefits to VersaPulse® laser surgery: Immediate results are visible; there is little, if any, discomfort; no numbing cream or injections are necessary for most patients; low risk of bruising; minimal swelling; and once the lesions are adequately treated, they usually do not return.
Do VersaPulse® laser treatments hurt?
Some patients say they feel a slight sting, like the snap of a rubber band on the skin. Post treatment sensations are similar to a mild feeling of sunburn. The VersaPulse® uses a special "chilled tip" to cool the skin during treatment -- this makes the treatment more tolerable as well as protects the skin. Most treatments do not require anesthetics.
What results can you expect?
Most patients will see improvement in their vascular lesions after the first treatment. This improvement can be quite dramatic. We document your results by using digital photography to map out your lesions pre- and post--operatively. However, as with any laser procedure, there is always a possibility that only minor changes will occur, and in rare cases, there is no response.
VersaPulse is a registered trademark of Lumenis Inc.